v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net increase (decrease) in net assets resulting from operations $ 3,418 $ 65,766
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net unrealized (appreciation) depreciation on investments 54,632 24,859
Net unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies 19 (100)
Net unrealized (appreciation) depreciation on interest rate swap attributed to unsecured notes (23) (61)
Net realized (gain) loss on investments 20,580 (587)
Net realized (gain) loss on foreign currency and other transactions 22 (53)
Investments in unaffiliated money market fund (1,381) (18,434)
Net accretion of discount and amortization of premium on investments (6,929) (8,153)
Payment-in-kind interest and dividend capitalized (11,338) (9,054)
Amortization of deferred financing costs 2,464 2,011
Amortization of debt issuance costs and original issuance discount on unsecured notes 2,339 2,412
Purchases of investments and change in payable for investments purchased (360,356) (409,840)
Proceeds from sale of investments and principal repayments and change in receivable for investments sold/repaid 490,767 409,700
Changes in operating assets and liabilities:    
(Increase) decrease in other assets 9,999 (385)
(Decrease) increase in payable to affiliates (40) 67
(Decrease) increase in management fees payable (414) 2,582
(Decrease) increase in income based incentive fees payable (763) 323
(Decrease) increase in interest payable (2,169) (4,987)
(Decrease) increase in accrued expenses and other liabilities (10,264) (3,185)
Net cash provided by (used in) operating activities 190,152 58,136
Cash flows from financing activities:    
Borrowings on debt 291,000 940,345
Repayments on debt (383,246) (874,000)
Deferred financing costs paid (4,380) (4,366)
Debt issuance costs paid (343) (4,078)
Distributions paid in cash (81,547) (97,145)
Proceeds from issuance of common stock, net of underwriting & offering costs 0 (123)
Repurchases of common stock (27,211) (30,009)
Net cash provided by (used in) financing activities (205,727) (69,376)
Net increase (decrease) in cash, cash equivalents and restricted cash (15,575) (11,240)
Effect of foreign exchange rate changes on cash (43) 60
Cash, cash equivalents and restricted cash, beginning of period 81,434 63,396
Cash, cash equivalents and restricted cash, end of period 65,816 52,216
Supplemental information and non-cash activities:    
Excise tax paid 2,792 2,567
Interest expense paid 60,676 69,326
Distributions payable 38,103 43,575
Non-cash purchases of investments (29,361) (5,010)
Non-cash sales of investments 29,361 5,010
Non-Controlled/Non-Affiliated Investments    
Changes in operating assets and liabilities:    
(Increase) decrease in interest and dividend receivable 2,662 5,301
Non-Controlled/Affiliated Investments    
Changes in operating assets and liabilities:    
(Increase) decrease in interest and dividend receivable (3,016) 0
Controlled/affiliated investments    
Changes in operating assets and liabilities:    
(Increase) decrease in interest and dividend receivable $ (57) $ (46)